Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Dupilumab may help treat alopecia areata without needing high IgE levels.

Certain medications can cause serious side effects, so it's important to report them.

Single-dose parenteral iron is safe and effective for children with inflammatory bowel disease and iron-deficiency anemia.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Apremilast improved symptoms in patients with severe skin conditions.

Psoriasis is linked to a higher risk of autoimmune diseases and other health conditions.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

The treatment was effective for lupus nephritis with manageable side effects.

Collagen CLR and placenta extract may help treat diffuse hair loss.

Omalizumab may cause hair loss.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Acitretin effectively treats severe hypertrophic lichen planus.

Secukinumab effectively treated a difficult case of folliculitis decalvans.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.